Teijin Limited (TSE:3401) agreed to acquire 86% stake in the medical business from Takiron Co.,Ltd. (TSE:4215) for ¥1.63 billion on January 24, 2017. Teijin Limited will rename the buisness as Teijin Medical Technologies Co., Ltd. Takiron Co.,Ltd. will retain 14% stake in Teijin Medical Technologies Co., Ltd. after the close of the transaction. A formal agreement for the share acquisition will be signed on January 24, 2017 and the transaction is expected to complete on July 3, 2017.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
865 JPY | +7.32% | +13.07% | +31.86% |
1st Jan change | Capi. | |
---|---|---|
+31.86% | 501M | |
+1.04% | 38.96B | |
-32.77% | 18.46B | |
+4.44% | 11.34B | |
-24.12% | 11.74B | |
+25.64% | 8.81B | |
-20.14% | 8.93B | |
-15.95% | 5.23B | |
-46.29% | 4.07B | |
-29.57% | 3.32B |
- Stock Market
- Equities
- 4215 Stock
- News C.I.TAKIRON Corporation
- Teijin Limited agreed to acquire 86% stake in the medical business from Takiron Co.,Ltd. for ¥1.63 billion.